Buy Online Mydekla 60mg

MyDekla ( Daclatasvir) is specifically indicated for use with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) of genotype 1, 3, or 4 infections. The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.

MyDekla ( Daclatasvir) stops HCV viral RNA replication and protein translation by directly inhibiting HCV protein NS5A. NS5A is critical for HCV viral transcription and translation,

MyDekla ( Daclatasvir)is supplied as tablets for oral administration. It is taken by mouth once a day. The recommended dose is 60 mg taken orally once daily with or without food in combination with sofosbuvir. The recommended treatment duration is 12 weeks. Dose modification: reduce dosage to 30 mg once daily with strong CYP3A inhibitors and increase dosage to 90 mg once daily with moderate CYP3A inducers.

Mechanism of Action

Daclatasvir When Used In Combination Treatment With Sofosbuvir May Result In Slowing Of The Heart Rate (Pulse) Along With Other Symptoms When Taken With Amiodarone, A Medicine Used To Treat Certain Heart Problems.

Daclatasvir Is a Direct-Acting Antiviral Agent (DAA) Against the Hepatitis C Virus.

Side effects

Tiredness, headache, nausea, or diarrhea may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.